Transfuse Marnetegragene in Periph Vein, Perc, New Tech 10

This code describes the administration of Marnetegragene Autotemcel, a gene therapy product, directly into a patient's peripheral vein. This procedure involves the infusion of the patient's own genetically modified cells, which have been processed to deliver therapeutic genes. It is a specialized treatment typically used for specific genetic disorders or cancers.

This code is used when a patient receives an infusion of Marnetegragene Autotemcel via a peripheral intravenous line. This typically occurs in a hospital inpatient setting for conditions requiring advanced gene therapy. It specifically applies to the initial or subsequent administration of this particular autologous gene therapy.

• Ensure documentation clearly specifies "Marnetegragene Autotemcel" as the substance infused, not just a generic gene therapy.
• Verify the approach was percutaneous into a peripheral vein; central venous access would necessitate a different approach code.
• Confirm the procedure was performed in an inpatient setting, as ICD-10-PCS is for inpatient procedures.